Inhibition of photocarcinogenesis by platelet-activating factor or serotonin receptor antagonists

Cancer Research

Volumn 68, Issue 10, 2008, Pages 3978-3984

  Sreevidya, Coimbatore S ^a   Khaskhely, Noor M ^a   Fukunaga, Atsushi ^a   Khaskina, Polina ^a   Ullrich, Stephen E ^a  

^a UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

1 (1 NAPHTHYL)PIPERAZINE; 1,4 DIHYDRO 2,4,6 TRIMETHYL 3,5 PYRIDINEDICARBOXYLIC ACID METHYL 2 PHENYLTHIOETHYL ESTER; 4 [5 (4 CHLOROPHENYL) 3 TRIFLUOROMETHYL 1H PYRAZOL 1 YL]BENZENESULFONAMIDE; [2 METHOXY 3 (N OCTADECYLCARBAMOYLOXY)PROPYL] (2 THIAZOLIOETHYL) PHOSPHATE; KETANSERIN; SEROTONIN 2A ANTAGONIST; SEROTONIN 2A RECEPTOR; THROMBOCYTE ACTIVATING FACTOR ANTAGONIST; THROMBOCYTE ACTIVATING FACTOR RECEPTOR; UROCANIC ACID; SEROTONIN ANTAGONIST; SEROTONIN RECEPTOR; THROMBOCYTE ACTIVATING FACTOR;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; CANCER INCIDENCE; CANCER INHIBITION; CONTROLLED STUDY; DRUG POTENTIATION; FEMALE; HAIRLESS MOUSE; IMMUNE DEFICIENCY; IN VIVO STUDY; MOUSE; NONHUMAN; PHOTORECEPTOR; PRIORITY JOURNAL; RADIATION EXPOSURE; SKIN CANCER; SKIN CARCINOGENESIS; SKIN HYPERTROPHY; SUNBURN; ULTRAVIOLET B RADIATION; ANIMAL; DRUG ANTAGONISM; EPIDERMIS; IMMUNE SYSTEM; INFLAMMATION; LIGHT; METABOLISM; PATHOLOGY; RADIATION INJURY; SKIN TUMOR; SUNLIGHT; ULTRAVIOLET RADIATION;

ANIMALS; APOPTOSIS; EPIDERMIS; FEMALE; IMMUNE SYSTEM; INFLAMMATION; LIGHT; MICE; NEOPLASMS, RADIATION-INDUCED; PLATELET ACTIVATING FACTOR; RECEPTORS, SEROTONIN; SEROTONIN ANTAGONISTS; SKIN NEOPLASMS; SUNLIGHT; ULTRAVIOLET RAYS;

EID: 45549106115     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: 10.1158/0008-5472.CAN-07-6132     Document Type: Article

References (29)

1. Urbach F. Ultraviolet radiation and skin cancer of humans. J Photochem Photobiol B 1997;40:3-7.
2. Elwood JM, Jopson J. Melanoma and sun exposure: an overview of published studies. Int J Cancer 1997;73:198-203.
3. Chen JG, Fleischer AB, Smith ED, et al. Cost of nonmelanoma skin cancer treatment in the United States. Dermatol Surg 2001;27:1035-8.
4. Housman TS, Feldman SR, Williford PM, et al. Skin cancer is among the most costly of all cancers to treat for the Medicare population. J Am Acad Dermatol 2003;48:425-9.
5. Kripke ML. Antigenicity of murine skin tumors induced by ultraviolet light. J Natl Cancer Inst 1974;53:1333-6.
6. Fisher MS, Kripke ML. Suppressor T lymphocytes control the development of primary skin cancers in ultraviolet-irradiated mice. Science 1982;216:1133-4.
7. Yoshikawa T, Rae V, Bruins-Slot W, Van den Berg JW, Taylor JR, Streilein JW. Susceptibility to effects of UVB radiation on induction of contact hypersensitivity as a risk factor for skin cancer in humans. J Invest Dermatol 1990;95:530-6.
8. Penn I. Post-transplant malignancy: the role of immunosuppression. Drug Saf 2000;23:101-13.
9. De Fabo EC, Noonan FP. Mechanism of immune suppression by ultraviolet irradiation in vivo. I. Evidence for the existence of a unique photoreceptor in skin and its role in photoimmunology. J Exp Med 1983;157:84-98.
10. Norval M, El-Ghorr AA. Studies to determine the immunomodulating effects of cis-urocanic acid. Methods 2002;28:63-70.
11. 2A receptor. Proc Natl Acad Sci U S A 2006;103:17420-5.
12. Pei Y, Barber LA, Murphy RC, et al. Activation of the epidermal platelet-activating factor receptor results in cytokine and cyclooxygenase-2 biosynthesis. J Immunol 1998;161:1954-61.
13. Walterscheid JP, Ullrich SE, Nghiem DX. Platelet-activating factor, a molecular sensor for cellular damage, activates systemic immune suppression. J Exp Med 2002;195:171-9.
14. Wolf P, Nghiem DX, Walterscheid JP, et al. Platelet-activating factor is crucial in psoralen and ultraviolet A-induced immune suppression, inflammation, and apoptosis. Am J Pathol 2006;169:795-805.
15. Kim TH, Ullrich SE, Ananthaswamy HN, Zimmerman S, Kripke ML. Suppression of delayed and contact hypersensitivity responses in mice have different UV dose responses. Photochem Photobiol 1998;68:738-44.
16. Kim TH, Ananthaswamy HN, Kripke ML, Ullrich SE. Advantages of using hairless mice versus haired mice to test sunscreen efficacy against photoimmune suppressions. Photochem Photobiol 2003;78:37-42.
17. Seibert K, Zhang Y, Leahy K, et al. Pharmacological and biochemical demonstration of the role of cyclooxygenase 2 in inflammation and pain. Proc Natl Acad Sci U S A 1994;91:12013-7.
18. Fischer SM, Lo HH, Gordon GB, et al. Chemopreventive activity of celecoxib, a specific cycloogenase-2 inhibitor, and indomethacin against ultraviolet-light induced skin carcinogenesis. Mol Carcinog 1999;25:231-40.
19. Pentland AP, Schoggins JW, Scott GA, Khan KNM, Han RJ. Reduction of UV-induced skin tumors in hairless mice by selective COX-2 inhibition. Carcinogenesis 1999;20:1939-44.
20. Ullrich SE. Mechanisms underlying UV-induced immune suppression. Mutat Res 2005;571:185-205.
21. Grewe M, Trefzer U, Ballhorn A, Gyufko K, Henninger H, Krutmann J. Analysis of the mechanism of ultraviolet (UV) B radiation-induced prostaglandin E2 synthesis by human epidermoid carcinoma cells. J Invest Dermatol 1993;101:528-31.
22. Soehnge H, Ouhtit A, Ananthaswamy HN. Mechanisms of induction of skin cancer by UV radiation. Front Biosci 1997;2:d538-51.
23. Melnikova VO, Ananthaswamy HN. Cellular and molecular events leading to the development of skin cancer. Mutat Res 2005;571:91-106.
24. Svobodova A, Zdarilova A, Maliskova J, Mikulkova H, Walterova D, Vostalova J. Attenuation of UVA-induced damage to human keratinocytes by silymarin. J Dermatol Sci 2007;46:21-30.
25. 2, IL-4, and IL-10 is responsible for UV-induced systemic immune suppression. J Immunol 1998;160:3783-9.
26. Barber LA, Spandau DF, Rathman SC, et al. Expression of the platelet-activating factor receptor results in enhanced ultraviolet B radiation-induced apoptosis in a human epidermal cell line. J Biol Chem 1998;273:18891-7.
27. Ma X, Bazan HE. Platelet-activating factor (PAF) enhances apoptosis induced by ultraviolet radiation in corneal epithelial cells through cytochrome c-caspase activation. Curr Eye Res 2001;23:326-35.
28. Rajesh KG, Suzuki R, Maeda H, Murio Y, Sasaguri S. 5-HT2 receptor blocker sarpogrelate prevents down-regulation of antiapoptotic protein Bcl-2 and protects the heart against ischemia-reperfusion injury. Life Sci 2006;79:1749-55.
29. Capela JP, Ruscher K, Lautenschlager M, et al. Ecstasy-induced cell death in cortical neuronal cultures is serotonin 2A-receptor-dependent and potentiated under hyperthermia. Neuroscience 2006;139:1069-81.